Transgene

Company Description

---

Transgene is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer.

A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer.

Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease.

Year founded

---

1979

Served area

---

Worldwide

Headcount

---

160

Headquarters

---

Parc d'Innovation 400 Boulevard Gonthier d Andernach, 67405 Illkirch Graffenstaden Cedex – France

Shares outstanding

---

100,204,071

IPO

---

Jan. 12, 2001

Stock exchange(s)

---

Euronext Paris